2025 Quality Assurance Reporting Requirements (QARR)

May 13, 2025

RE: Clarification #1 for Measurement Year (MY)
2025 Updates

Dear Colleague,

This letter contains information about the 2025 Quality Assurance Reporting Requirements (QARR) Technical Specifications and updates to the following documents: the MY2025 Technical Specifications, the NYS MY2025 QARR List of Required Measures (Table1), the MY2025 PLD File Specifications (PDF), and MY2025 Value sets. The files are posted on our Managed Care Information for Health Plans page. The revised specifications should be used in the plans' processing for MY2025 QARR.

This clarification includes the following changes made to the 2025 QARR Technical Specifications Manual.

Change Version Version Date Section(s) Changed Change Summary
1 04/30/25 QARR MY2025
Technical Specifications
  1. The Audit Requirements (Section III) and Reporting Schedule (Section IV) reporting due dates have been updated to align with the HEDIS MY 2025 Audit Timeline.
  2. NYS Measure - Continued Engagement in Substance Use Disorder (SUD) Treatment (CET) specifications have been updated for align with MAT dispensing guidelines.
  3. Prenatal Care Measures - updated reporting requirement: Hospital of Delivery (PFI) to Facility ID.
  4. Added Section IX. Facility ID Instructions - provides
    guidance for downloading Facility IDs from the Health Data NY website.
MY2025 Value Sets
  1. The following MY2025 Value Sets have been added to the QARR Reporting guidelines webpage referenced above.
    • Language Value Set
      • SIGN language (171) has been added for MY2025
    • NYS QARR Medication List
  2. The NYS QARR Value Set has been updated to align with HEDIS specifications.
Patient- Level Detail File (PLD) MY2025 - All Lines of Business (LOB)
  1. Chlamydia Screening in Women (CHL): - Name Change Updated the measure title from Chlamydia Screening in Women to Chlamydia Screening to align with HEDIS specifications.
  2. Kidney Health Evaluation for Patients With Diabetes (KED):
    Age stratifications have been adjusted to align with HEDIS specifications. Updated to report three age stratifications and a total rate:
    • 18-64.
    • 65-75.
    • 76-85.
    • Total.
    The total is the sum of the age stratifications.
  3. Breast Cancer Screening (BCS-E):
    Updated Breast Cancer Screening (BCS-E) age stratification to align with HEDIS specifications.
MY2025 Table 1: QARR List of Required Measures
  1. Eye Exam for Patients With Diabetes (EED):
    Removed the Hybrid Data Collection Method to align with updated HEDIS specifications.

If there are any questions about the above edits, or if you find issues or have concerns with the MY2025 Technical Specifications manual or other documents, please email nysqarr@health.ny.gov.

Sincerely,

Paloma Luisi, MPH
Director, Bureau of Quality Measurement & Evaluation
Center for Applied Research and Evaluation
Office of Health Services Quality and Analytics

CC:  R. Josberger
        E. Nichols
        C. Fan